Based on the genetic association of GPR39 SNPs with markers of VCI and changes in GPR39 expression in postmortem human brain, we tested the hypothesis that GPR39 plays a protective role against cognitive impairment, mediated in part via oxylipins actions on CBF and neuroinflammation. The gene discussed is GPR39; the disease is Cognitive impairment.